Podcast: Play in new window | Download (Duration: 7:51 — 10.8MB)

Subscribe: Apple Podcasts | Android | Email | RSS

A popular Abortion Pill on trial

The Fifth U.S. Circuit Court of Appeals is considering a case regarding FDA approval of Mifepristone two decades ago.

Texas OB/GYN Dr. Ingrid Skop has provided expert testimony in trials involving Mifepristone, based on her medical research. On the June 1 Family Life Noon Report, Bob Price had an extended interview with Dr. Skop, about what she sees as dangers of the abortion-inducing drug, not only (obviously) to the fetus, but also for a significant number of the women who have taken the pill. There is question about how the FDA studied and reported on Mifepristone’s side effects, as well as how much of the national discussion misnames abortions as a women’s health issue.

Whichever way the appeals court ruling in New Orleans comes out, likely during June, the case is expected to return to the U.S. Supreme Court.

For further information:

• Details on the original court case, which resulted in a temporary restraining order from a Texas judge in early 2023.
• Dr. Skop writes for Feminists for Life and the Charlotte Lozier Institute with details about her research.
  
• Dr. Skop, on media bias in reporting on pro-life and pro-abortion positions.